ShareValue scores for BFRI: Valuation 53, Quality 41, Growth 54, Health 46.

BFRI
NASDAQ

Biofrontera Inc

$1.25(+0.81%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 17%
Valuation
53
Fair Value
Price vs Value
Quality
41
Moderate
Business Strength
Growth
54
Moderate
Revenue & Earnings
Health
46
Moderate
Financial Stability
Momentum
67
Bullish
Price Trend

Company Details

About

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts. Address: 660 Main Street, Woburn, MA, United States, 01801

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026